Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

immunity · Mechanism Report

Are IL6 rs1800795 GG and SH2B3 rs3184504 TT linked to stronger inflammatory signaling and higher innate immune-cell counts?

These genetic patterns are associated with stronger inflammatory signaling and more active myeloid immune-cell responses, which can align with higher CRP and innate immune-cell counts.

PlausibleJuly 8, 202617 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

IL6 rs1800795 GG and SH2B3 rs3184504 TT are genetic patterns associated with stronger inflammatory signaling or myeloid immune-cell responses, which can fit with above-optimal CRP and innate immune-cell counts.

laying out figure…
2 of 5 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says IL6 rs1800795 GG and SH2B3 rs3184504 TT can track with a more inflammatory baseline. The mechanism graph frames this as increased inflammatory signaling and enhanced myeloid output, which can raise CRP and innate immune-cell counts. The IL6 pattern is more context-dependent, while SH2B3 TT is the more consistently supported driver of this immune profile.

Verified conclusion

Genetic variations in inflammatory and hematopoietic regulators, specifically IL6 and SH2B3, directly modulate systemic inflammatory baselines and innate immune cell production.

Clinical and phenotypic impacts

  • SH2B3 rs3184504 TT: This genotype is strongly associated with elevated white blood cell indices, neutrophil-predominant leukocytosis, and enhanced leukocyte mobilization under inflammatory stress. It elevates upstream drivers of systemic inflammation, including cell adhesion molecules like VCAM-1, which ultimately influence downstream C-reactive protein (CRP) production.
  • IL6 rs1800795 GG: This variant presents a highly context-dependent phenotype. While the GG genotype is linked to higher CRP concentrations in specific cohorts, such as overweight renal transplant recipients, other populations (including obese individuals) show higher CRP with the CC genotype. Its direct effect on baseline leukocyte counts is variable and lacks consistent epidemiological support.

Mechanistic explanations

  • SH2B3 rs3184504 TT: This genotype encodes a hypomorphic, partial loss-of-function R262W variant of the LNK adaptor protein. LNK normally acts as a crucial negative regulator of cytokine signaling by binding activated JAK2 and JAK3. The R262W alteration weakens this inhibition, resulting in enhanced JAK2-STAT signaling downstream of key cytokine receptors like MPL and EPOR. This signaling cascade drives myeloid-biased progenitor expansion (myelopoiesis) and robust myeloid immune-cell output.
  • IL6 rs1800795 GG: This functional –174 G/C promoter polymorphism directly alters IL6 transcription. Elevated IL-6 expression acts as the primary upstream stimulator of hepatic CRP synthesis during the acute-phase response and modulates the recruitment, survival, and dynamics of myeloid immune cells, including neutrophils and monocytes.

Bottom line

  • The SH2B3 rs3184504 TT genotype reliably drives elevated innate immune-cell counts and heightened inflammatory signaling via enhanced JAK2-STAT pathway activation, whereas the IL6 rs1800795 GG genotype acts as a highly context-dependent modulator of IL-6 expression and hepatic CRP synthesis.

References

  1. Association of genetic variations of interleukin-6 polymorphism ... — explorationpub.com ↗
  2. Trait: Inflammation and IL-6 | FitnessGenes® — fitnessgenes.com ↗
  3. Impacts of pro‐inflammatory cytokines variant on cardiometabolic profile and premature coronary artery disease: A systematic review and meta‐analysis — pmc.ncbi.nlm.nih.gov ↗
  4. The Interleukin-6 Gene Promoter Polymorphism -174 and Atherosclerotic Events in Overweight Transplanted Patients — pmc.ncbi.nlm.nih.gov ↗
  5. VCV000014718.25 - ClinVar - NCBI - NIH — ncbi.nlm.nih.gov ↗
  6. Pleiotropy and Specificity: Insights from the... : Immunity - Ovid — ovid.com ↗
  7. The interleukin-6 –174 G/C promoter polymorphism and arterial stiffness; the Rotterdam Study — pmc.ncbi.nlm.nih.gov ↗
  8. IL-6 regulates induction of C-reactive protein gene expression by ... — pmc.ncbi.nlm.nih.gov ↗
  9. [PDF] Rethinking IL-6 and CRP: Why They Are More Than Inflammatory ... — iris.unito.it ↗
  10. The Longevity-Associated SH2B3 (LNK) Genetic Variant - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  11. The autoimmune risk R262W variant of the adaptor SH2B3 improves ... — pmc.ncbi.nlm.nih.gov ↗
  12. LNK/SH2B3 Loss of Function Promotes Atherosclerosis and ... — ahajournals.org ↗
  13. The Role of LNK (SH2B3) in the Regulation of JAK-STAT Signalling in Haematopoiesis — mdpi.com ↗
  14. Reduced function of the adaptor SH2B3 promotes T1D via altered ... — biorxiv.org ↗
  15. The genetic architecture of plasma kynurenine includes ... - Nature — nature.com ↗
  16. SH2B3 - an overview | ScienceDirect Topics — sciencedirect.com ↗
  17. Diagnostic relevance of SH2B3 mutations in suspected myeloid ... — nature.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesDoes low-normal vitamin D weaken immune resilience?→Plausible11 sourcesCan low zinc and low vitamin D constrain immune pathways while an optimal hs-CRP does not support active systemic inflammation?→